SUMMARY.-This study indicated that: (1) i.p. inoculation of protamine into (Rauscher) leukemic mice increased their 9 death time, (2) protamine was more toxic for leukemic than normal mice and (3) the in vitro reaction between Rauscher virus and protamine reduced its infectivity for mice.
PROTAMINE complexes with nucleic acid in the sperm of salmon (salmine) and other fish (Kay, 1966) . In mice it inhibited the growth of Landschutz ascites and sarcoma 180 tumors (Muggleton, MacLaren and Dyke, 1964) . However, in vitro incubation of N.J.A. leukemic cells with protamine before inoculation into mice failed to inhibit the development of leukemia (Larson and Olson, 1968) .
Our study investigated what effects protamine had on Rauscher virus induced murine leukemia and, in a separate experiment, Rauscher virus infectivity in mice after in vitro incubation with protamine.
MATERIALS AND METHODS
In the following experiments all dilutions were made in phosphate (0-01m) buffered saline (0-15m) pH 7-4 (PBS) and BALB/c/Tex inbred mice were utilized.
In vivo 8tudim
Day-old mice were inoculated intraperitoneally (i.p.) with 0-05 of a suspension containing 50-100 MLD50 of Rauscher leukemia virus (MLD50 minimum concentration of virus killing 50% of test mice). When post inoculation mortality and hepatosplenomegaly were present, mice were divided into subgroups. Then leukemic mice in a subgroup were each inoculated i.p. three times per week for 6 weeks with one of the following concentrations of protamine sulfate/10 g. of body weight: (1) 0-2 mg., (2) 0-4 mg., (3) 0-6 mg. and (4) 1-0 mg. Control mice, the same age, consisted of: (1) normal noninoculated, isolated, (2) normal, isolated and inoculated with 1-0 mg. of protamine as described above, and (3) (Reed and Muench, 1938) .
Preliminary studies indicated that in vitro incubation of virus and protamine at 20' C. for 30 minutes gave the most reproducible results, and therefore, was used in this study. The concentrations of protamine reacted in vitro with the Rauscher virus were based upon weight ratios (average weight of newborn-I g.), and approximated those described in Table I . The average weight of spleens used for SD50 calculations was 650 mg. with a range of 315-2200 mg. Necropsies on the viral control mice and those inoculated with virus and protamine which expired before 60 days showed gross lesions similar to those described under Tablel. ControlmiceinoculatedwithO-Img.,0-05mg.orO-025mg.ofprotamine showed no mortality or evidence of hepatosplenomegaly.
DISCUSSION
Our study indicated that intraperitoneal inoculation of protamine into leukemic mice prolonged their 1 death time and the in vitro reaction of protamine and the Rauscher murine leukemia virus reduced its infectivity for mice. The nature of neither inhibition was determined. Studies by others suggested possible modes of action.
One inhibitor of murine leukemia viruses is interferon (Isaacs and Linderman, 1957) . Administered passively, it inhibited the in vivo development of viral (Friend) murine leukemia (Gressler et al., 1967) . These viruses are also inhibited in vivo by treatment with interferon inducing synthetic products (Padman, et al., 1969) or statalon (Wheelock, 1967) .
However, leukemia susceptible adult BALB/c mice which produced high interferon levels after non-leukemia viral induction, produced lower levels after Rauscher virus inoculation (Peries, Boiron and Canivet, 1965; Glasgow and Friedman, 1969) . In contrast leukemia resistant adult CD-1 mice inoculated with Rauscher virus developed higher serum levels of interferon than BALB/c mice (Glasgow and Friedman, 1969) . This suggested a relationship between resistance to murine leukemia and interferon production. In the case of protamine, its ability to induce or potentiate interferon production in leukemic mice must be considered.
Nucleohistones (Bonner and T'so, 1966) are considered inducers or potentiators of interferon's cellular reactions (Stan'ek and Matisova', 1968) (Li eat al., 1963) . Protamine is known to react with viruses in vitro and reduce their infectivity (Warren et al., 1949) . Our study indicated that the in vitro reaction between Rauscher virus and protamine reduced its infectivity for mice. However, it is not known whether this interaction was involved in the in vivo inhibition of this virus.
The above studies suggested that protamine inhibited viral replication by inducing interferon production or reacted directly on the " complete " leukemia virus. These considerations concerned the leukemic process in the host. Knowledge of protamine's other effects in vivo should be considered. Protamine at 2 mg.110 g. body wt was toxic for normal mice (Yartiainen and Marble, 1941) . At I mg./10 g. body wt we found it toxic for erythroleukemic mice. Such toxicity may be related to its anticoagulative effect (Waldschmidt-Leitz, Stadler and Steigerwaldt, 1929) .
We postulated that leukemic cells with a higher negative surface charge than normal cells (Ambrose, James and Lowick, 1956 ) concentrated in the liver and spleen. Interaction with protamine caused a local excess of protamine in these tissues.
